If you have been through a CDD process, or are preparing for one, you already know the report surfaces the gaps. What it does not give you is a commercial response. This article explains what those gaps typically are in B2B businesses, what a credible response looks like, and how to build a 100-day plan that gives investors and management teams confidence the thesis will hold.
Specifically, you will learn: what commercial due diligence actually exposes about sales execution and pipeline discipline in complex B2B environments; why the report and the plan are two entirely different things; and how to build a structured commercial response that turns findings into a repeatable route to revenue. If you are working with a PE-backed business and need that response built quickly, our Commercial Performance Diagnostic is the structured starting point.
Commercial due diligence is a structured assessment of a business’s commercial position, conducted ahead of an investment, acquisition or sale. It examines market size and dynamics, competitive positioning, revenue quality, customer concentration, and the credibility of the management team’s growth plan. Firms like PwC, L.E.K. Consulting and BCG run these processes for private equity buyers and corporate acquirers across mid-market and large-cap deals.
The scope typically covers market assessment, competitive analysis, revenue growth analysis, customer feedback interviews and scrutiny of the business plan. The output is a report that tells the investor whether the commercial thesis is credible, and where the risks sit.
What it tends to find, particularly in B2B businesses with complex or long-cycle sales, is a consistent set of structural weaknesses. Pipeline data that cannot be trusted. A proposition that means different things to different sellers. Sales execution that depends on a handful of individuals rather than a repeatable process. These are not unusual findings. They are the norm.
Financial due diligence examines the historical accuracy of reported numbers – revenue, margins, working capital, debt. Commercial due diligence examines whether those numbers can grow. It asks whether the market supports the growth plan, whether the business can win in that market, and whether the commercial model is built to deliver. The two disciplines are complementary, but they answer different questions. A business can have clean financials and a broken commercial system.
Across the B2B businesses we work with at salesengine.co.uk, the commercial weaknesses that CDD most reliably surfaces fall into four categories.
The first is pipeline discipline. Most businesses cannot show a clean, stage-gated pipeline with consistent qualification criteria. Deals sit in the funnel for months without clear next steps. Forecasting is based on optimism rather than evidence. When a CDD team asks for pipeline data, what they receive often tells a different story from the revenue plan.
The second is proposition clarity. In complex B2B environments, the same product or service is described differently by every seller. There is no shared language for value, no consistent articulation of outcomes, and no clear differentiation from competitors. Customer interviews during CDD frequently reveal that buyers cannot explain why they chose the business – which is a significant risk signal for any investor.
The third is sales execution dependency. Many mid-market B2B businesses have grown through the effort of a small number of high-performing individuals, often including the founder. The commercial model is not repeatable because it lives in people’s heads rather than in a structured process. CDD exposes this quickly.
The fourth is the gap between what is sold and what is delivered. Customer success and delivery are often disconnected from the sales process. Promises made during the deal are not tracked post-signature. Renewal risk is invisible until it becomes churn. This is the baton drop that our CORD methodology is specifically designed to close.
Quorum Cyber, a PE-backed cybersecurity business we worked with, had exactly this profile: strong technical capability, a growing market, but a sales operation that was founder-dependent and lacked the commercial discipline to scale. We helped professionalise the sales operation, embed repeatable deal discipline and support strategic opportunities. The result was over £2m in wins directly supported – not because the product changed, but because the commercial execution did.
This is the point that almost no one in the CDD market addresses directly. The report tells you what is wrong. It does not tell you how to fix it, in what order, or who should own it. That gap is where investment theses quietly unravel.
A CDD report might identify that the business lacks a consistent sales process. That finding is accurate and important. But it does not tell you whether the priority is qualification discipline, proposal quality, pipeline stage gating, or sales manager coaching. It does not tell you what to do in the first 30 days versus the first 90. It does not tell you who in the management team has the capability to lead the change.
PE operating partners know this problem well. The report lands, the deal closes, and then the commercial improvement work begins, often without a structured plan, often without the right commercial leadership in place, and almost always under time pressure from the investment committee.
The businesses that navigate this well treat the CDD findings as a diagnostic input, not a conclusion. They use the report to prioritise, then build a structured commercial response with clear owners, milestones and metrics. That is the 100-day revenue plan – and it is the thing the CDD report cannot give you.
The management teams that perform best under CDD scrutiny are the ones who have already done the diagnostic work on their own commercial system. They can show a clean pipeline with consistent stage definitions. They can articulate the proposition clearly and consistently. They have customer references who can speak to outcomes, not just satisfaction. And they have a revenue growth plan that is built on commercial logic rather than aspiration.
Practically, this means three things. First, get your pipeline data in order. Know your conversion rates by stage, your average deal size, your sales cycle length and your win/loss ratio. If you cannot produce this data confidently, a CDD team will notice. Second, align your commercial narrative. Every member of the leadership team should be able to describe the proposition, the target customer and the competitive differentiation in the same terms. Third, document your sales process. Even a basic, written stage-gate process signals commercial maturity to an investor.
Vendigital, a UK management consultancy we worked with ahead of its acquisition by Siemens Advanta, is a strong example of what this preparation can achieve. The commercial plan built there contributed to a 25% turnover increase in 18 months and a threefold increase in client wins ahead of the sale; see the full case study. The commercial work done before and during the process gave the business the credibility to support the deal thesis.
If you are working with PE-backed businesses with complex sales environments, the preparation window before a CDD process is one of the highest-value periods in the investment cycle. Use it.
A 100-day revenue plan is not a strategy document. It is an execution plan. It takes the findings from a CDD report – or from a structured commercial diagnostic – and translates them into a prioritised sequence of actions with clear owners, timelines and success metrics.
The structure we use at salesengine.co.uk follows a consistent pattern. The first 30 days focus on commercial visibility: getting accurate pipeline data, aligning the leadership team on priorities, and identifying the two or three commercial blockers with the highest impact on near-term revenue. The next 30 days focus on process and enablement: building or strengthening the sales process, sharpening the proposition, and putting the right stage-gating and qualification discipline in place. The final 30 days focus on execution rhythm: embedding the new process through coaching, deal reviews and pipeline discipline, and establishing the reporting cadence that gives the board commercial visibility.
This is not theory. A global software reseller and digital transformation consultancy we worked with needed to align ten European sales teams around a shared commercial approach after a period of rapid growth. We built a shared playbook, clearer forecasting standards and a consistent way to sell a new digital transformation proposition. The result was commercial standards implemented across all ten teams – not through a lengthy transformation programme, but through a structured, sequenced 100-day approach.
The 100-day plan works because it is specific enough to be actionable and short enough to maintain momentum. It also gives the investment committee something concrete to track – which matters enormously in the first year post-close.
Buy-side commercial due diligence is commissioned by the acquirer or investor to assess the target business before committing capital. Vendor due diligence (VDD) is commissioned by the seller to provide a pre-prepared assessment that can be shared with potential buyers, speeding up the process and reducing information asymmetry. BCG describes VDD as adopting a buyer’s perspective on the asset being sold – the goal is to anticipate the questions a buyer will ask and answer them credibly before they are asked.
What changes between the two is the commissioning party and the timing. What stays the same is the substance: market position, revenue quality, commercial model credibility and growth plan robustness are assessed in both cases. The commercial weaknesses that VDD surfaces are identical to those that buy-side CDD finds: pipeline discipline, proposition clarity, sales execution dependency, and delivery risk.
For management teams, VDD is an opportunity. It gives you the chance to identify and address commercial weaknesses before a buyer does. A well-prepared VDD, backed by genuine commercial improvement work, can materially strengthen deal value and reduce the risk of price chips during negotiation.
The best CDD work goes beyond market sizing and competitive mapping. It asks whether the commercial model is built to deliver the growth plan – and whether the management team has the capability and the process to execute it. According to BCG’s vendor due diligence practice, the most valuable assessments create a compelling storyline that enables buyers to understand precisely why an asset is valuable and how it fits their strategy.
In practice, this means CDD consultants are looking for evidence of commercial repeatability. Can the business win deals without the founder in the room? Is the pipeline a reliable indicator of future revenue? Do customers renew and expand, or do they churn quietly? These are the questions that determine whether the investment thesis is credible.
For sales execution support that addresses these questions directly, the work needs to happen at the level of process, capability and commercial discipline – not just at the level of strategy. A well-structured CDD process will expose the difference between a business that has a good strategy and one that can actually execute it.
Most CDD processes run between four and eight weeks, depending on deal complexity, sector and the scope of customer interviews required. Mid-market deals handled by firms like Whitecap Consulting typically run at the shorter end of this range. Larger, more complex transactions involving multiple geographies or product lines can extend to ten or twelve weeks. The timeline is usually driven by the deal process rather than the CDD scope – which means the commercial assessment is often compressed into a window that does not allow for deep remediation work. That is precisely why the post-close commercial plan matters so much.
The investment thesis is a promise. It says the business will grow in a specific way, at a specific rate, over a specific period. Commercial due diligence assesses whether that promise is credible at the point of investment. What happens after close determines whether it is kept.
The businesses that deliver on their investment thesis share a common characteristic: they treat the commercial system as a connected whole, not a set of separate functions. Marketing generates demand that sales can convert. Sales makes promises that customer success can deliver. The handoffs between these functions are designed, not assumed. This is the structural principle behind our CORD methodology – Collaborate, Outcomes, Refine and Deliver – which connects the customer, the seller and the customer success function from the start of the commercial relationship.
The SDR team at a PE-backed UK connectivity provider we worked with is a useful illustration of what this looks like at the top of the funnel. Through call reviews, coaching and structured enablement, we built a repeatable rhythm for better conversations and more reliable pipeline generation. The result was SDRs consistently booking 8 to 10 meetings per month – not through a one-off training event, but through a sustained, structured approach to commercial capability.
The gap between a CDD report and a delivered investment thesis is a commercial execution problem. It requires operator-led support, a structured plan and the discipline to follow through. If your business is at this point – post-close, post-report, or preparing for either – our fractional commercial leadership and go-to-market strategy services are built for exactly this stage. Start with a Commercial Performance Diagnostic and leave with a 100-day revenue plan that gives your leadership team and your investors something concrete to act on.
Commercial due diligence consulting involves an independent assessment of a business’s commercial position ahead of an investment or acquisition. This typically covers market size and dynamics, competitive landscape analysis, revenue quality and growth plan credibility, customer reference interviews and scrutiny of the management team’s business plan. The output is a structured report that tells the investor or acquirer whether the commercial thesis is credible and where the material risks sit. In B2B businesses with complex sales, the assessment will also examine pipeline discipline, sales execution maturity and the quality of the customer relationship model.
Financial due diligence examines the historical accuracy of a business’s reported financial performance – revenue recognition, margins, working capital and debt. Commercial due diligence examines whether those numbers can grow. It assesses the market opportunity, the competitive position and the credibility of the commercial model. The two disciplines are complementary but answer different questions: financial DD tells you what happened, commercial DD tells you what is likely to happen next. A business can have clean financials and a fundamentally broken commercial system – CDD is designed to surface that distinction before capital is committed.
CDD firms are looking for evidence that the commercial model is repeatable and that the growth plan is credible. Specifically, they examine whether the business can win deals without depending on one or two key individuals, whether the pipeline is a reliable indicator of future revenue, whether customers renew and expand or churn quietly, and whether the proposition is differentiated in a way that buyers actually value. The most rigorous CDD processes also assess the management team’s capability to execute the growth plan – not just whether the plan is well-written, but whether the team has the commercial discipline and process to deliver it.
Most commercial due diligence processes run between four and eight weeks, though this varies significantly by deal complexity, sector and the scope of customer interviews required. Mid-market transactions typically sit at the shorter end of this range. Larger deals involving multiple geographies, product lines or complex competitive dynamics can extend to ten or twelve weeks. The timeline is usually driven by the deal process rather than the CDD scope, which means the commercial assessment is often compressed. This compression is one of the reasons why post-close commercial planning is so important – there is rarely enough time during the CDD process to address the weaknesses it identifies.
Vendor due diligence is commissioned by the seller rather than the buyer. The seller appoints a CDD firm to produce an independent assessment of the business that can be shared with potential acquirers, reducing information asymmetry and speeding up the deal process. Buy-side CDD is commissioned by the acquirer to independently validate the seller’s claims. The substance of both assessments is largely the same – market position, revenue quality, commercial model credibility – but VDD gives the management team an opportunity to identify and address commercial weaknesses before a buyer does. A well-prepared VDD, backed by genuine commercial improvement work, can materially strengthen deal value and reduce the risk of price renegotiation during the transaction.
The management teams that perform best under CDD scrutiny have done the diagnostic work on their own commercial system before the process begins. This means having clean, stage-gated pipeline data with consistent qualification criteria and reliable conversion metrics. It means aligning the leadership team on a clear, consistent articulation of the proposition and competitive differentiation. And it means documenting the sales process so that commercial maturity is visible, not just asserted. Customer references who can speak to specific outcomes – not just general satisfaction – are also a significant credibility signal. The preparation window before a CDD process is one of the highest-value periods in the investment cycle.
After the CDD report is delivered, the investor uses the findings to make a final investment decision, negotiate deal terms or structure post-close conditions. For the management team, the report marks the beginning of the commercial improvement work, not the end. The findings need to be translated into a prioritised action plan with clear owners, timelines and success metrics – what we call a 100-day revenue plan. This plan addresses the commercial gaps the CDD identified, in the sequence that will have the greatest impact on near-term revenue and investment thesis delivery. Without this structured response, CDD findings tend to sit in a report rather than drive the commercial change the business needs.
New to Sales Engine? Begin with the Commercial Performance Diagnostic.
